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Highlights
 Wearable trackers have acceptable accuracy, especially for measuring step counts, 
moderate to vigorous physical activityMVPA, ECG and HRheart rate, and for 
electrocardiography, but not for measuring respiratory rate (RR).
 Most older adults have reported ease of use and also demonstrated high-level adherence 
over daily long-term use.
 Methodological designs for data collection were have been heterogeneous and currently 
there are no standardised methods for quantifying data from wearable devices in older 
adults. As such f
 Frameworks and / or guidelines, are needed to support the ongoing use of wearable trackers 
to capture the physical activity of older adults.
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Abstract
Background: Wearable trackers as research or clinical tools are increasingly used to support the care 
of older adults, due to their practicality in self-monitoring and potential to promote healthy lifestyle 
behaviours. However, there is limited understanding of appropriate data collection methods and 
analysis for  methods in different contexts still exists. 
Aim: To summarise evidence on wearable data generation and management in older adults, focusing 
on physical activity (PA), electrocardiogram (ECG), and vital signs monitoring. In addition to examine 
the accuracy and utility of incorporating wearable trackers into the care of older people.  
Methods: A systematic search of CINAHL, MEDLINE, PubMed and a manual search were conducted. 
Twenty studies targeting on the use of wearable trackers use by in older adults met the inclusion 
criteria.
Results: Methodological designs for data collection and analysis were heterogeneous, with diverse 
definitions of wear and no-wear time, the number and type of valid days, and proprietary 
algorithms. Wearable trackers had adequate accuracy for measuring step counts, moderate to 
vigorous physical activity (MVPA), ECG and heart rate (HR), but not for respiratory rate. Participants 
reported ease of use and had high-level adherence over daily long-term use. Moreover, wearable 
trackers encouraged users to increase their daily PA level of physical activity and decrease waist 
circumference, facilitating atrial fibrillation (AF) diagnoses and predicting length of stay.
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Conclusion: Wearable trackers are multi-dimensional technologies offering a viable and promising 
approach for sustained and scaled monitoring of older people’s health. Frameworks and/or 
guidelines, including standards for the design, data management and application of use specifically 
for older adults, is are required to enhance validity and reliability. 
Keywords
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1. Introduction 
Aging populations with their high prevalence of chronic diseases have a significant impact on the 
healthcare system of any country. Fortunately, extraordinary advances in wearable tracker 
technology promote the potential to meet the demands of the healthcare system and facilitate the 
care of older adults. Notably, a wide array of commercial wearable trackers have recently appeared 
on the market. These trackers are inexpensive and are equipped with advanced functionality that 
utilises proprietary sensor technologies and data processing formulas to offer users a real-time 
assessment of their physiological, physical, psychological, and behavioural data [1, 2]. This includes 
data on heart rate (HR), blood pressure (BP), respiration rate (RR), electrocardiogram (ECG), and 
physical activity (PA) levels [1, 2]. Therefore, wearable trackers offer a practical alternative for 
everyday monitoring of PA, ECG and vital signs [2].  
Although older adults perceive wearable trackers as beneficial and acceptable [3], the fast advances 
in wearable technology and the diverse methods of data processing have resulted in a lack of 
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standards of practice for monitoring calibration and validation and field application, such as for the 
objective monitoring of PA [4]. Specifically, how to collect, calibrate, process, and use data from 
wearable trackers continues to be one of the critical challenges when using these devices [4]. It is 
also important to note that accelerometry assumptions for the selection of cut-points and data 
analysis are not standardised across research protocols [5, 6]. Most research guiding accelerometry 
data analysis methods is derived from studies that involved children and young adults [5, 7, 8], and 
there is limited research on accelerometry data in older adults6. Consequently, the primary aim of 
this paper is to present a systematic review of wearable data generation and management in older 
adults focusing on PA, ECG and vital signs monitoring (i.e., HR, BP, and RR). The secondary aim is to 
examine accuracy and the utility of incorporating wearable trackers into the care of older adults.  
2. Methods
Both an electronic database search of CINAHL, MEDLINE, PubMed and a manual search were 
performed to identify the relevant articles. The search included the following terms: (1) ‘sensor’ or 
‘monitor’ or ‘device or ‘tracker’, and (2) ‘wearable’. We limited our search to adults aged 65 years 
and older using relevant Medical Subject Headings. We included studies which met the following 
criteria: (1) published in English and targeted older population (i.e.,  65 years old), (2) specifically 
investigated health-related wearable trackers; (3) study outcome focused on PA (i.e., active minutes 
and step counts), ECG, and vital signs monitoring. We excluded studies that primarily involved 
traditional pedometers or research grade trackers such as the ActiGraph accelerometer. We also 
excluded studies that mainly examined ‘gait’ and ‘falls’ because a recent published review9 has 
already summarised the current literature on older adult’s gait assessment through use of 
wearables. 
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Using the above keywords, the initial search retrieved 485 studies of which 20 were eligible for full 
review (Figure 1). Any disagreements about inclusion were resolved through conversation between 
two team members (MA and RG). The Critical Appraisal Skills Programme (Cohort Study) Checklist 
was used to assess the quality of the reviewed studies. On assessment, although five of the studies 
met a minimum 80% of the evaluation criteria, the majority of the included studies were of poor to 
moderate quality. The findings of the reviewed studies were extracted manually and summarised in 
tables.
3. Results 
3.1 Overview of the wearable trackers included in the reviewed studies
Twelve different wearable trackers and 20 studies were included in this review (Table 1). Trackers 
include: ADAMO Care Watch, Fitbit Charge HR, Fitbit Flex, Fitbit One, Fitbit Zip, HealthPatch MD, 
iRhythmZio, Jawbone UP, MagIC, Misfit Shin, Nike+FuelBand, and Polar A300. The most commonly 
used wearable trackers across all reviewed studies were Fitbit One (n=7) and Fitbit Charge HR (n=4). 
It should be noted, there is a high turnover rate of wearable trackers available on the market so that 
one of the trackers reviewed, Jawbone UP, discontinued in 2011.   
3.2 Data acquisition in the reviewed studies 
The sample characteristics of the 20 included studies, wearable tracker name, data collection 
method, and analysis protocols are summarised in Table 2. The majority of the reviewed studies had 
PA as their focus (n=15), followed by ECG (n=3) and then vital signs (n=2).
The sample sizes ranged from eight to 2659 (total 3741 participants). The overall mean age was 69 
years and almost all studies (n=18) included both males and females, with the minority of 
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participants, females (42%). The diagnoses varied widely among the studies, but almost half the 
studies (n=8) included participants who had or were at high risk of cardiovascular disease. Twelve 
studies were conducted in a free-living environment, 6 studies were conducted in a controlled 
environment, and 2 studies utilised both controlled and free-living environments. The wearable 
trackers were placed on the wrist (n=12), waist (n=8), chest (n=4), ankle (n=2) and pocket (n=2). 
Data collection, and analysis protocols were heterogeneous.  The overall duration of the data 
collection ranged from two minutes to eight months. Among the studies conduction in a free-living 
environment, the tracker wear time was during all waking hours (i.e. valid day with ≥10 wear 
hours/day) in three studies, and for 24 hours in 11 studies. The definition of wear time varied among 
the reviewed studies. For instance, a cut-off threshold of 150 minutes [10] or 60 minutes [11] of 
continuous zero data from the wearable tracker was deemed as being non-wear data. Participants 
were required to wear the tracker for at least seven consecutive wearing days in over half of the 
included studies (11 of 20); at least five consecutive wearing days in one study; at least four 
consecutive wearing days including weekend days and weekdays in one study; with the remaining 
studies (7 of 20) including three consecutive wearing days or less. The algorithms and classifiers used 
for the feature computation varied among the reviewed studies. The majority of studies utilised 
proprietary algorithms that set its sampling interval at 60 seconds, but the shorter epochs (15 
seconds) were reported in one study. Similarly, almost all of the studies used proprietary algorithms 
(not known to the authors, as the formulas are proprietary to the company) to define the cut point 
of the measured outcomes; for example, minutes of moderate to vigorous physical activity (MVPA). 
Two studies utilised clinicians (e.g., cardiologists) to manually score and classify the data.   
3.3 Data accuracy: Outcomes of the reviewed studies in terms of reliability and/or validity 
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Twelve [1,10,23,26-29,31-33,38-39] of the 20 reviewed studies targeted validity and/or reliability 
(Table 3). Overall, eight studies examined the validity and/or reliability of different wearable trackers 
in measuring step counts [10,26-29,32,33]. The outcomes of these studies supported the validity and 
reliability of the wearable trackers in tracking step counts but noted that walking at slow speeds and 
wrist-worn trackers may affect their accuracy. Two studies highlighted the capabilities of wearable 
trackers in accurately tracking active minutes of PA, especially MVPA [30,31]. Similarly, two studies 
showed wearable trackers had acceptable validity for measuring HR [38,39]. One study found that 
wearable trackers provide an accurate ECG reading [23]. However, one study warned against the use 
of wearable trackers for measuring respiratory rate as its accuracy was outside acceptable limits 
[38]. 
3.4 Data utility: Outcomes of the reviewed studies regarding the clinical benefits of wearable trackers 
and their acceptability
Eight of the 20 reviewed studies targeted the data utility of wearable trackers (Table 4). Four [24-
25,34,37] of the eight studies centred focused on the usefulness of wearable trackers as a measure 
of clinical outcomes, three studies [3,11,34] focused on the participants’ acceptance, adoption or 
abandonment of wearable trackers, one study [36] included both of the aforementioned aims, and 
one study examined the usefulness of wearable trackers as a motivational tool for PA behaviour 
change.
Regarding the clinical benefits, one study found a significant relationship between steps taken, 
length of stay, and dismissal disposition [37]. One study showed self-monitoring of PA using 
wearable trackers decreased waist circumference significantly [35], and two studies highlighted that 
wearable self-applied ECG patches facilitated AF diagnoses [24,25]. Moreover, one study [36] 
showed that feedback from a PA wearable tracker motivates behaviour change. Regarding the 
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wearable tracker acceptability, three [3,11,35] studies found that participants reported the wearable 
trackers were easy to use and they also had high-level adherence over daily long-term use. However, 
one study [34] found that abandonment-related issues influencing daily long-term use of wearable 
trackers involved the collection of inaccurate data, time wasting, and wearing discomfort. 
4. Discussion  
Our results showed that overall, wearable trackers had adequate accuracy, especially for measuring 
step counts, MVPA, ECG and HR, but not for measuring RR. Moreover, most participants reported 
ease of use and also demonstrated high-level adherence over daily long-term use. Some 
participants, however, found the wearable trackers very difficult to use, and it is therefore important 
to consider the usability, comfort and feasibility of the trackers for older participants. Importantly, 
wearable trackers have become standard objective methods for assessing health outcomes such as 
PA. They have also demonstrated the usefulness of wearable technology for encouraging users to 
increase their daily PA level and to decrease their waist circumference, facilitating AF diagnoses and 
predicting hospital length of stay [24, 35, 37]. Therefore, wearable trackers may be promising for use 
among this cohort to help in diagnosing, monitoring and encouraging sustained changes in healthy 
behaviours such as PA. 
Importantly, our findings highlighted that methodological designs for data collection were 
heterogeneous and that there is no standardised method for quantifying data from wearable 
devices in older adults. Given the lack of a universally accepted definition [12, 13] for data collection 
and analysis of wearable trackers, future research is needed to produce specific assumptions for this 
work that is most applicable for older people, particularly accounting for their physical capacity. It is 
vital to standardise tracker placement and the number and type of valid days needed to achieve 
acceptable validity and reliability to ensure comparability across study outcomes. For example, the 
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most common practice for PA measurement is a minimum of four days of valid data for analysis, 
including weekend days [14].  It is also critical to standardise the definitions of wear time and no-
wear time. For instance, the criteria for no-wear time most commonly applied is removal of the 
tracker for 60 minutes or more of continuous zeros, with allowance of 1-2 minutes [15], but 90 
minutes has been proposed for older people with limited mobility [16]. 
Of note, almost all the review studies relied on tracker proprietary algorithms, which set the 
sampling interval at different short or long epochs. Thus, a standardised algorithm or cut points to 
define an outcome (e.g. MVPA) are critical to support the tracker validity and reliability. A 
considerable amount of time and effort has been invested by researchers and manufacturers to 
make sure the algorithms in wearable trackers accurately measure clinical outcomes such as PA 
level. However, this pursuit presents numerous issues and challenges for stakeholders; namely, 
clinicians, researchers, tracker manufactures and patients [1]. Algorithms to aggregate raw tracker 
data into operational variables are regularly modified and frequently not available [17]. For instance, 
the Fitbit manufacturer recently modified the algorithm used to count active minutes without 
notification. All stakeholders are therefore eager to ensure tracker accuracy facilitates the precise 
monitoring of PA and other important health outcomes. Hence, wearable tracker manufacturers 
need to ensure the algorithm delivers high-level accuracy equal to research-grade accelerometers 
(e.g. Actigraph) and to inform stakeholders when modifications to the algorithms occur to uphold 
their trust. 
There are difficulties in ensuring the literature remains up to date on current models due to the 
frequency of new releases of wearable trackers17. Moreover, consideration must be given to the 
high turnover rate of wearable trackers in the market and that some trackers are no longer 
produced (e.g. Jawbone). The wide range of tracker features (e.g. step counts, active minutes and 
energy expenditure) also complicates the practicality and accuracy of wearable trackers in 
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
measuring health outcomes such as all dimensions of PA [17]. Uncertainties around the ownership 
of data and therefore accessibility to the data for research purposes also presents challenges to 
review boards in institutions as essentially it is data collection from third parties [1, 18]. In addition, 
there are issues regarding data structure and quality due to tracker manufacturers not sharing the 
data or their data collection methods with researchers [1, 18, 19]. Lastly, given we live in the digital 
personal health era, issues may emerge over data privacy [1, 18]. Hence, future research is needed 
to generate studies on privacy policies of wearable trackers and also to review federal and state 
legislation related to data protection.  
Notably, the acceptable level of inaccuracy varied and often was not clearly defined. Indeed, even in 
the literature there is no widely agreed definition of acceptable degree of error for PA wearable 
trackers. Acceptable measurement error for PA under controlled conditions or for research purposes 
is suggested to be within ±3% [20, 21], and under free-living conditions is within ±10% [20, 21]. 
Other literature advises that errors of less than 20% have acceptable validity for clinical purposes 
[22]. Depending upon the work being studied and the purposes of the validation study, it is 
important for future studies with elderly participants to standardise the analysis methods in order to 
guide validity interpretation for wearable trackers and to highlight the different validity criteria 
between the tested and criterion measures for clinical purposes compared to research purposes. 
Finally, it is worth noting that gender differences are likely, yet seldom examined. Only one study 
[30] analysed data separately by gender using Fitbit-Flex noted that male participants recorded 
significantly more steps and higher MVPA minutes than their female counterparts. 
Several limitations need to be acknowledged. We searched only a limited number of databases and 
reviewed articles published in English only so some studies may have been missed. Also, there is 
insufficient reporting for the accelerometry assumptions in several of the reviewed studies, creating 
difficulty for fully evaluating the accelerometer protocol. 
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5. Implications for practice and future research
The findings of this review have a number of important implications:
1. Wearable trackers are generally valid, reliable and/or feasible when tracking step counts, 
MVPA, ECG and HR in aging populations. Thus, trackers may be ideal to help in diagnosing, 
measuring, monitoring and/or motivating in this population cohort.  
2. There needs to be a framework and/or guidelines and a standardised method for the 
collection and analysis of wearable tracker data specifically for older people’s physical 
capacity.
3. Manufacturers of trackers must ensure the tracker algorithm delivers a high level of 
accuracy similar to a research-grade accelerometer.
4. Although there is extensive validity and reliability research available, there are no studies 
examining the responsiveness of wearable trackers. Thus, further research is needed to 
develop evidence-based responsiveness. 
6. Conclusion 
A definitive recommendation for a wearable tracker or method of data collection and analysis could 
not be made due to lack of strong evidence as the majority of primary studies used proprietary 
algorithms and there is no way to access the primary data. However, wearable trackers are generally 
valid, affordable and useful for monitoring a number of clinical outcomes such as PA, ECG and vital 
signs in real-time, and for accounting for day-to-day variations. This encourages more accurate and 
personalised clinical intervention for older people. Wearable trackers are promising tools for 
clinicians to manage the care of older people, however, the validity and reliability of wearable 
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trackers are impacted by a number of factors including fast-paced technological developments, 
frequent updates to algorithms by manufacturers, and an absence of a consensus protocol for data 
collection and analysis. Future research is encouraged to develop guidelines and standards for the 
design and application of wearable technology in aging populations.
Contributors
Muaddi Alharbi contributed to the concept, design and conduct of the review, analysis and writing of 
the manuscript.
Nicola Straiton contributed to the concept and design of the review, and writing of the manuscript.
Sidney Smith contributed to the analysis and writing of the manuscript.
Lis Neubeck contributed to the analysis and writing of the manuscript.
Robyn Gallagher contributed to the concept and design of the review, analysis and writing of the 
manuscript. 
Conflict of interest 
The authors declare that they have no conflict of interest.
Funding
No funding was received for the preparation of this review.
Funding sources 
None. 
Disclosures 
None. 
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
Conflict of interest 
The authors report no relationships that could be construed as a conflict of interest. 
Provenance and peer review 
This article has undergone peer review.
References
1. Alharbi M, Straiton N and Gallagher R. Harnessing the potential of wearable activity trackers 
for heart failure self-care. Curr Heart Fail Rep. 2017; 14: 23-9.
2. Walker RK, Hickey AM and Freedson PS. Advantages and limitations of wearable activity 
trackers: Considerations for patients and clinicians. Clin J Oncol Nurs. 2016; 20: 606-10.
3. McMahon SK, Lewis B, Oakes M, Guan W, Wyman JF and Rothman AJ. Older adults' 
experiences using a commercially available monitor to self-track their physical activity. JMIR 
Mhealth Uhealth. 2016; 4: 35-45.
4. Freedson P, Bowles HR, Troiano R and Haskell W. Assessment of physical activity using 
wearable monitors: Recommendations for monitor calibration and use in the field. Med Sci 
Sports Exerc. 2012; 44: 1-4.
5. Masse LC, Fuemmeler BF, Anderson CB, et al. Accelerometer data reduction: A comparison 
of four reduction algorithms on select outcome variables. Med Sci Sports Exerc. 2005; 37: 
544-54.
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
6. Gorman E, Hanson H, Yang P, Khan K, Liu-Ambrose T and Ashe M. Accelerometry analysis of 
physical activity and sedentary behavior in older adults: A systematic review and data 
analysis. Eur Rev Aging Phys Act. 2014; 11: 35-49.
7. Matthews CE. Calibration of accelerometer output for adults. Med Sci Sports Exerc. 2005; 37: 
512-22.
8. Reilly JJ, Penpraze V, Hislop J, Davies G, Grant S and Paton JY. Objective measurement of 
physical activity and sedentary behaviour: Review with new data. Arch Dis Child. 2008; 93: 
614-9.
9. Godfrey A. Wearables for independent living in older adults: Gait and falls. Maturitas. 2017; 
100: 16-26.
10. Farina N and Lowry RG. The validity of consumer-level activity monitors in healthy older 
adults in free-living conditions. J Aging Phys Act. 2018; 26: 128-35.
11. Speier W, Dzubur E, Zide M, et al. Evaluating utility and compliance in a patient-based 
eHealth study using continuous-time heart rate and activity trackers. J Am Med Inform 
Assoc. 2018; 1: 1386-91.
12. Hagströmer M, Oja P and Sjöström M. Physical activity and inactivity in an adult population 
assessed by accelerometry. Med Sci Sports Exerc. 2007; 39: 1502-8.
13. Alharbi M, Bauman A, Neubeck L and Gallagher R. Measuring overall physical activity for 
cardiac rehabilitation participants: A review of the literature. Heart Lung Circ. 2017; 17: 1-18.
14. Tudor-Locke C, Camhi SM and Troiano RP. A catalog of rules, variables, and definitions 
applied to accelerometer data in the National Health and Nutrition Examination Survey, 
2003-2006. Prev Chronic Dis. 2012; 9: 113-29.
15. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T and McDowell M. Physical activity in the 
United States measured by accelerometer. Med Sci Sports Exerc. 2008; 40: 181-8.
16. Choi L, Ward SC, Schnelle JF and Buchowski MS. Assessment of wear/nonwear time 
classification algorithms for triaxial accelerometer. Med Sci Sports Exerc. 2012; 44: 2009-16.
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
17. Cadmus-Bertram L. Using fitness trackers in clinical research: what nurse practitioners need 
to know. J Nurse Pract. 2017; 13: 34-40.
18. Wright SP, Brown TSH, Collier SR and Sandberg K. How consumer physical activity monitors 
could transform human physiology research. Am J Physiol Regul Integr Comp Physiol. 2017; 
312: 358-67.
19. Alharbi M, Gallagher, R., Neubeck, L., Bauman,  B., Gallagher, P., . Not all steps are equal: 
Changing algorithms in wearable trackers changes outcomes. BJSM Blog, 2017.
20. Schneider PL, Crouter SE and Bassett DR. Pedometer measures of free-living physical 
activity: Comparison of 13 models. Med Sci Sports Exerc. 2004; 36: 331-5.
21. Tudor-Locke C, Sisson SB, Lee SM, Craig CL, Plotnikoff RC and Bauman A. Evaluation of 
quality of commercial pedometers. Can J Public Health. 2006; 1: 10-5.
22. Schneider PL, Crouter SE, Lukajic O and Bassett DR. Accuracy and reliability of 10 
pedometers for measuring steps over a 400-m walk. Med Sci Sports Exerc. 2003; 35: 1779-
84.
23. Di Rienzo M, Racca V, Rizzo F, et al. Evaluation of a textile-based wearable system for the 
electrocardiogram monitoring in cardiac patients. Europace. 2013; 15: 607-12.
24. Steinhubl SR, Waalen J, Edwards AM, et al. Effect of a Home-Based Wearable Continuous 
ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS 
Randomized Clinical Trial. JAMA. 2018; 320: 146-55.
25. Turakhia MP, Ullal AJ, Hoang DD, et al. Feasibility of extended ambulatory electrocardiogram 
monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for 
Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015; 38: 285-92.
26. Magistro D, Brustio PR, Ivaldi M, et al. Validation of the ADAMO Care Watch for step 
counting in older adults. PLoS One. 2018; 13: e0190753.
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
27. Burton E, Hill KD, Lautenschlager NT, et al. Reliability and validity of two fitness tracker 
devices in the laboratory and home environment for older community-dwelling people. BMC 
Geriatr. 2018; 18: 103.
28. Paul SS, Tiedemann A, Hassett LM, et al. Validity of the Fitbit activity tracker for measuring 
steps in community-dwelling older adults. BMJ Open Sport Exerc Med. 2015; 1: 1-5.
29. Simpson LA, Eng JJ, Klassen TD, et al. Capturing step counts at slow walking speeds in older 
adults: comparison of ankle and waist placement of measuring device. J Rehabil Med. 2015; 
47: 830-5.
30. Alharbi M, Bauman A, Neubeck L and Gallagher R. Validation of Fitbit-Flex as a measure of 
free-living physical activity in a community-based phase III cardiac rehabilitation population. 
Eur J Prev Cardiol. 2016; 23: 1476-85.
31. Boeselt T, Spielmanns M, Nell C, et al. Validity and usability of physical activity monitoring in 
patients with chronic obstructive pulmonary disease (COPD). PLoS One. 2016; 11: e0157229.
32. Floegel TA, Florez-Pregonero A, Hekler EB and Buman MP. Validation of consumer-based hip 
and wrist activity monitors in older adults with varied ambulatory abilities. J Gerontol A Biol 
Sci Med Sci. 2017; 72: 229-36.
33. Thorup CB, Andreasen JJ, Sorensen EE, Gronkjaer M, Dinesen BI and Hansen J. Accuracy of a 
step counter during treadmill and daily life walking by healthy adults and patients with 
cardiac disease. BMJ Open. 2017; 7: e011742.
34. Fausset CB, Mitzner TL, Price CE, Jones BD, Fain BW and Rogers WA. Older adults’ use of and 
attitudes toward activity monitoring technologies. Proc Hum Factors Ergon Soc Annu Meet. 
2013; 57: 1683-7.
35. O'Brien T, Troutman-Jordan M, Hathaway D, Armstrong S and Moore M. Acceptability of 
wristband activity trackers among community dwelling older adults. Geriatr Nurs. 2015; 36: 
21-5.
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
36. Kanai M, Izawa KP, Kobayashi M, et al. Effect of accelerometer-based feedback on physical 
activity in hospitalized patients with ischemic stroke: A randomized controlled trial. Clin 
Rehabil. 2018; 32: 1047-56.
37. Cook DJ, Thompson JE, Prinsen SK, Dearani JA and Deschamps C. Functional recovery in the 
elderly after major surgery: Assessment of mobility recovery using wireless technology. Ann 
Thorac Surg. 2013; 96: 1057-61.
38. Breteler MJMM, Huizinga E, van Loon K, et al. Reliability of wireless monitoring using a 
wearable patch sensor in high-risk surgical patients at a step-down unit in the Netherlands: 
A clinical validation study. BMJ Open. 2018; 8: e020162.
39. Kroll RR, Boyd JG and Maslove DM. Accuracy of a wrist-worn wearable device for monitoring 
heart rates in hospital inpatients: A prospective observational study. J Med Internet Res. 
2016; 18: 253-64.
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
Figure 1. Search Strategy
Id
en
tif
ic
at
io
n
Sc
re
en
in
g
El
ig
ib
ili
ty
In
cl
ud
ed
Records identified through 
database and hand searches
n= 485
Records excluded after title and 
abstract screening
n= 445
Full-text articles assessed for 
eligibility  
n= 40
Studies included
n= 20
Full-text articles excluded 
n= 20 
Table 1: Wearable trackers included in the review
Tracker Released date What is measured Software Battery life
ADAMO Care Watch 2010 Steps, distance,
calories, active
minutes
On screen summary 
online-feedback, also 
phone apps
21 days
Fitbit Charge HR Jan 2015 Steps, distance,
calories, active
minutes, sleep, HR
On screen summary 
online-feedback, also 
phone apps
5 days
Fitbit Flex May 2013 Steps, distance,
calories, active
minutes, sleep
Online-feedback, also 
phone apps
7–10 days
Fitbit One Sep 2012 Steps, distance,
calories, active
minutes, sleep
On screen summary 
online-feedback, also 
phone apps
14 days 
Fitbit Zip May 2013 Steps, distance,
calories, active
minutes, sleep
On screen summary 
Online-feedback, also 
phone app
4–6 months
HealthPatch MD Jan 2015 Single-Lead ECG, HR, 
HR Variability, vital 
signs, fall detection, 
steps  
Online-feedback, also 
phone apps
3-5 days
iRhythmZioXT Jan 2011 Single-Lead ECG, HR Online-feedback, also 
phone apps
14 days
Jawbone UP Nov 2011
(Note: Dec 2011 
discontinued)
Steps, calories,
distance, sleep
Online-feedback, also 
phone apps
10 days
MagIC: a textile-based 
wearable system
April 2009 ECG, respiratory 
frequency and motion
Online-feedback, also 
phone apps
3 days
Misfit Shine Dec 2013 Steps, distance,
calories, active
minutes, sleep
Online-feedback, also 
phone apps
4-6 months
Nike+ FuelBand Nov 2013 Steps, calories Online-feedback, also 
phone apps
4 days
Polar A300 Feb 2015 Steps, distance,
calories, active
minutes, sleep, HR
On screen summary 
Online-feedback, also 
phone apps.
26 days 
Table 2: Summary of data acquisition in the reviewed studies: wearable specific population, data collection, and analysis details 
Authors / 
setting
Sample Wearable 
tracker
Wearable 
locations
Measure(s)
tested
Data 
collection 
setting
Instructions
for wear
Data collection Epoch 
used
for 
analysis
Data cleaning Cut points 
ECG
Di Rienzo et 
al.23
Italy 
N = 50 CR 
patients 
Age:67
Female: 0
MagIC: a 
textile-based 
wearable 
system 
Chest Cardiac 
rhythm and 
arrhythmic 
events
Controlled Wear at all 
times during 
the test
60m for each 
participant
200Hz NR Data manually 
scored by two
cardiologists 
Steinhubl et 
al.24 
USA
N = 2659 at 
risk of AF
Age:73
Female: 1026 
(39%)
iRhythmZio Chest ECG patch 
facilitated AF 
diagnosis
Free-living 
 
Wear patch 
for up to 2 
weeks 
During first 
and last 2 
weeks of 4-
month period 
beginning 
immediately or 
4 months after
enrolment, 
respectively
30s Individuals in
monitored 
cohort not 
wearing a 
patch were 
assumed not
to have AF 
unless 
identified via 
claims data as 
having AF
Incidence of 
newly diagnosed 
AF defined as 
≥30 seconds
of AF or flutter 
detected by 
tracker 
Turakhia et 
al.25 
USA
N = 75 at risk 
of AF 
Age:70
Female: 0 
(0%)
iRhythmZio Chest ECG patch 
facilitated AF 
diagnosis
Free-living Wear patches
for up to 2 
weeks
14 days of 
uninterrupted
monitoring
30s Excluded data 
for repeated 
or subsequent 
Zio Patch 
monitoring to 
minimize 
confounding 
by indication
Each AF episode 
defined
as presence of 
≥30 seconds of 
continuous AF
during 
monitoring.
Cardiovascular 
technicians
confirm and 
classify 
arrhythmia
diagnoses 
PA
Magistro et 
al.26 
Italy
N = 20 older 
participants  
Age:75
Female 10 
(50%)
ADAMO Care 
Watch
Wrist Steps Controlled Wear at all 
times during 
the test 
Procedure 
took 60m 
50Hz A step was 
defined as a 
negative slope 
of the 
combined 
acceleration 
pattern
when  
acceleration 
curve crossed 
below 
dynamic 
threshold
The dynamic 
threshold level 
was estimated 
via the max. and 
min. values of 
the bursts 
retrieved, and 
the average
value, (max + 
min) divided by 2
Burton et al.27 
Australia
N = 31 older 
participants  
Age:74
Female 20 
(65%)
Fitbit Flex
Fitbit
Charge HR
Wrist Steps Controlled 
and
free-living
Wear for 14-
days including 
sleeping
7 days; direct 
observation on 
days 1 and 7
14 days; 24h 
for free-living 
period
60s Missing data 
eliminated in 
the analysis 
Used proprietary 
algorithms
Paul et al.28
Australia
N = 32 older 
participants  
Age:68
Female: 20 
(63%)
Fitbit One 
Fitbit Zip
Waist Steps Controlled 
and free-
living  
Wear during a 
2m walk test 
(2MWT) and 
then wear 
them during 
waking hours
2m for each 
participant
7-day; during 
waking hours 
60s No definition 
for wear time. 
Data checked 
against 
participants’ 
activity logs 
for 
inconsistencies 
- erroneous 
data removed
Used proprietary 
algorithms
Simpson et 
al.29
Canada
N = 42 older 
adults 
Age:72
Female: 32 
(74%)
Fitbit One Waist
Ankle 
Steps Controlled Wear during 
walking for 
a distance of 
15m with 8 
different 
walking trials
During a single 
testing session  
60s NR Used proprietary 
algorithms
Alharbi et 
al.30
Australia 
N = 48 CR 
patients 
Age:66
Female:23 
(48%)
Fitbit Flex Wrist Steps & 
MVPA 
Free-living Wear tracker 
during waking 
hours
4 consecutives
days (2 
weekend days 
and 2 week 
days) during 
waking hours
60s Valid day at 
least 10h from 
time awoke in 
morning until 
time to bed at 
night
Used proprietary 
algorithms
Boeselt et 
al.31
Germany 
N = 20 
Patients with 
chronic
obstructive 
pulmonary 
disease
Age:66
Female:3 
(15%)
Polar A300 Wrist Calories,
daily activity 
time
(h) and METS
Free-living Wear at all 
times.
3 consecutive
days, 24h 
60s 100% of 
sample above 
crucial number 
of steps/day, 
activity tracker 
comparison
data in all 
patients.
• Light- activity = 
1.1 to 2.9 METs
 • Moderate- 
activity = 3.0 to 
5.9 METs
 • Vigorous- 
activity = 6.0 or > 
METs
Floegel et 
al.32
USA 
N = 99 older 
participants
Age:79
Female:25 
(71%)
Fitbit One
Fitbit Flex
 
Jawbone UP
Waist 
Wrist 
Waist 
Wrist 
Steps Controlled Wear at all 
times during 
the test
During a single 
testing session  
60s 
(Fitbit)
30Hz 
(Jawbone 
UP)
NR Used proprietary 
algorithms
Thorup et 
al.33
Denmark 
N = 24 
Cardiac 
patients 
Age:67
Female:2 (8%)
Fitbit Zip Waist Steps Free-living Wear at all 
times during 
free-living 
activities
1 day; 24h 
(during 
hospitalisation) 
and 4 weeks; 
24h
(thereafter at 
home; mean 
28.2, range
26–31)
60s NR Used proprietary 
algorithms
Farina et al.10
UK
N = 25 
Cardiac 
patients 
Age:73
Misfit Shine Waist 
Wrist 
Steps Free-living Wear during 
waking hours
(except for 
water-based 
activities)
7 consecutive 
days, during 
waking hours
60s Non-wear 
data: A cut-off 
threshold of 
150m of 
Used proprietary 
algorithms 
Female:12 
(48%) Fitbit
Charge HR Wrist
continuous 
zero data
A valid day:  at 
least 10h/day.
Minimum of 4 
days of valid 
data required 
for inclusion in 
analysis
Speier et al.11
USA
N = 200 
Cardiac 
patients 
Age:65
Female: NR
Fitbit
Charge HR
Wrist Adherence to 
wearable 
tracker based 
on  
sedentary, 
Active 
minutes, and 
non-wear 
time  
Free-living Wear at all 
times
Over 90 days, 
24h
60s A valid day:  at 
least 10h/day
Non-wear 
time: 
NHANES). 
estimated 
using 
continuous
bouts of zero 
activity counts 
lasting longer 
than 60 
minutes,
allowing for up 
to two 
minutes of 
activity. 
Determined by 
HR at hour 
(HR-h) or 
minute (HR-m) 
level
Used proprietary 
algorithms
Fausset et 
al.34
USA
 N = 8 older 
participants  
Age:65
Female: 4 
(50%)
Fitbit
One
Nike+ 
FuelBand 
 
 
Pocket 
Pocket 
Wrist 
Attitudes 
toward PA 
monitoring 
technology 
Free-living Wear at all 
times
2 weeks 60s NR Used proprietary 
algorithms
McMahon et 
al.3 
USA
 N = 95 older 
adults   
Age:70
Female: 71 
(75%)
 Fitbit One  Waist Attitudes 
toward PA 
monitoring 
technology
 Free-living Wear at all 
times
 Throughout 8-
month study 
 60s  2 users 
dropped out 
after acutel 
illness.
Used proprietary 
algorithms
O’Brien et 
al.35
USA
 N = 34 older 
adults 
Age:74
Female: 22 
(65%)
Nike+ 
FuelBand 
Wrist Steps, 
calories
Free-living Wear at all 
times
12-week;, daily 
for 24h a day
60s 5 of the 34 
participants
dropped out 
because they 
did not want
to wear the 
activity tracker 
every day
Used proprietary 
algorithms
Kanai et al.36
Japan
N = 55 
inpatients 
with 
ischaemic 
stroke
Age:65
Female: 28 
(51%)
Fitbit One Waist Steps; light, 
moderate,
and vigorous 
PA
Free-living Wear at all 
times 
Daily; 24h until 
discharge
from 
supervised 
rehabilitation 5 
to 6 
times/week. 
Mean length of 
hospital stay 
11 to 12
days
60s PA defined at 
baseline
as day 2 after 
enrolment 
because
patients did 
not wear 
accelerometer 
for 24h
on day 1
Used proprietary 
algorithms
Cook et al.37
USA 
N = 149 a 
postop. 
cardiac 
surgical 
patients 
Age:68
Female:66  
(44%)
Fitbit One Ankle Steps Free-living Trackers 
placed on
patients’ 
ankles after 
transition 
from ICU
Daily for 5 days 
(LOS)
60s Two 
participants 
died and 
excluded from 
analysis
Used proprietary 
algorithms
Vital signs
Breteler et 
al.38
Netherlands
N = 25 
postoperative 
surgical 
patients 
Age:65 
HealthPatch 
MD 
Chest Respiratory 
and heart
rate
Controlled Attached at 
all times 
during the 
test
1–3 days; 24h 15m Empty or 
invalid data 
(not-a-
number) 
removed to 
bradycardia (HR 
<50 beats/m), 
tachycardia HR 
>100 beats/m), 
Female 7 
(28%)
obtain 
continuous 2D 
vectors of vital 
sign samples 
with 
corresponding 
time stamps
bradypnoea (RR 
<12 breaths/
m) and 
tachypnoea (RR 
>20 breaths/m)
Kroll et al.39
Canada
N = 50 ICU 
patients 
Age:65
Female: 24 
(48%)
Fitbit Charge 
HR
Wrist HR Controlled Wear at all 
times
One day; 24h 60s Trackers not 
reassessed for 
duration of 
24h
recording 
period. High 
frequency
data captured 
from 
continuous 
bedside 
monitoring to 
provide 
accurate gold
standard 
assessment of 
HR and 
analysed 
tracker 
performance 
on both 
pooled and 
per-patient
level
Used proprietary 
algorithms
CR = cardiac rehabilitation; ECG = Electrocardiography; PA = physical activity; AF = atrial fibrillation; LOS = length of stay; ICU = intensive care unit; METs = metabolic equivalent tasks; NR = not 
reported; h = hours; m = minutes; s = seconds; Hz = hertz 
Table 3: Data accuracy: Outcomes of the reviewed studies in terms of reliability and/or validity
 
Authors Data collection 
settings/methods
Data 
comparison 
time/
distance
Wearable 
tracker
Measure(s)
tested
Cross-
validation 
measure
Main conclusions
Magistro 
et al.26
Controlled
Performed several 
randomly ordered 
tasks: walking at 
slow, normal and 
fast self-paced 
speeds; a Timed Up 
and Go test (TUG); 
a step test and 
ascending/
descending stairs
Procedure 
took 60m 
ADAMO 
Care Watch
Steps Steps 
observed and 
counted with 
a manual tally 
counter
ADAMO Care 
Watch 
demonstrated 
highly accurate
measurements of 
steps count in all 
activities, 
particularly 
walking at normal 
and slow speeds
Burton et 
al.27 
Controlled and
free-living
2MWT: walk 
without assistance 
as
fast and safe as 
permissible for 2m. 
Free-living activities  
7 days; direct 
observation 
on day 1 and 
7
14 days; 24h 
for free-living 
period
Fitbit Flex
Fitbit
Charge HR
Steps Visual step 
count
(video 
recording)
GENEactiv 
acceleromete
r
Good reliability 
and validity of the 
Flex and 
ChargeHR, 
however both 
trackers 
underestimated 
step count in the 
laboratory 
environment
Breteler 
et al.28
Controlled 
Attached both the 
wireless sensor and
bedside routine 
standard for at least 
24h
1–3 days; 24h Health
Patch MD 
Respiratory 
and heart
rate
XPREZZON:
ICU grade’
patient 
monitoring 
system.
Accurate
measurement of 
HR, but not for 
respiratory rate
Kroll et 
al.39
Controlled
Continued to collect 
data for the full 24h 
period
One day; 24h Fitbit 
Charge HR
HR BedMaster-
EX, Excel 
Medical, 
Jupiter: ICU 
bedside 
continuous 
ECG monitors
Tracker–derived 
HRs were slightly 
lower than those 
derived from 
continuous ECG 
monitoring in 
real-world
testing and not as 
accurate as pulse 
oximetry- derived 
HRs
Di Rienzo 
et al.23
Controlled
In 20 patients with 
severe clinical 
conditions, 
recording was 30m 
while subjects at 
rest in bed in the 
hospital cardiac unit
60m for each 
participant
MagIC: a 
textile-
based 
wearable 
system
Cardiac 
rhythm and 
arrhythmic 
events
Fukuda 
Denshi 
telemetric 
ECG (mod
DS 5700, 
Tokyo, Japan): 
Traditional 
ECG
tracker:
In static condition 
MagIC accurate in 
monitoring 
cardiac rhythm 
and arrhythmic 
events and 
comparable to 
that obtained by 
a traditional one-
lead ECG 
recorder. During 
With remaining 20 
patients, ECGs were 
performed for 36m 
during physical 
rehab. sessions 
according to
protocol: at rest 
(4m lying, 1m 
standing), during 
mild
calisthenic PA 
(10m), while 
pedalling a 
cycloergometer
(15m) and during a 
6MWT.
movement MagIC 
provides an ECG 
signal of better 
quality
Paul et 
al.28
Controlled and free-
living
  
Wore trackers
simultaneously 
during a 2MWT and 
then during free-
living activities 
2m for each 
participant
7-day; during 
waking hours
Fitbit One 
Fitbit Zip
Steps ActiGraph
 
Visual step 
count 
(2MWT)
Fitbit accurately 
tracked steps
during the 
2MWT. There 
was strong 
agreement
between Fitbit 
and ActiGraph 
counted steps
Simpson 
et al.29
Controlled 
Participants walked
a distance of 15 
metres for 8 
different walking 
trials
During a 
single testing 
session  
Fitbit One Steps Visual step 
count
(video 
recording)
Fitbit accurately 
captured steps at
slow speeds 
when placed at 
the ankle 
Alharbi et 
al.30
Free-living
Wear both trackers 
simultaneously 
during free-living 
activities
4 
consecutives
days (two 
weekend days 
and two 
weekdays) 
during waking 
hours
Fitbit Flex Steps
MVPA
ActiGraph Fitbit- is a valid, 
reliable and 
alternative 
tracker for 
activity 
monitoring 
specific to 
predicted 
attainment of PA 
guideline 
recommendation
s for step counts 
and minutes
of MVPA)
Boeselt et 
al.31
Free-living
Wear at all times 
during free-living 
activities
3 consecutive
days; 24h
Polar A300 Calories,
daily 
activity 
time
(h) and 
METS
Bodymedia
SWA
Polar tracker 
equivalent to 
SWA  for 
assessment
of PA time, step 
count and calorie 
consumption in 
COPD patients
 
Floegel et 
al.32
Controlled During a 
single testing 
session  
Fitbit One
Fitbit Flex
Steps StepWatch StepWatch, Fitbit 
One, and 
Jawbone UP 
Instructed to walk 
at self-selected 
pace along an
unobstructed 100 
metre 
predetermined, flat 
marked route at 
their respective
community centre 
location
 
Omron HJ-
112,
Jawbone UP
(direct 
observation 
through
continuous 
videography)
accurate at 
measuring steps
Thorup et 
al.33
Free-living
Wear at all times 
during free-living 
activities
1day; 24h 
(during 
hospitalisatio
n) and 4 
weeks; 24h
(thereafter at 
home mean 
28.2, range
26–31)
Fitbit Zip Steps Shimmer3 A speed of 3.6 
km/h or higher is
required for 
acceptable 
accuracy in step
measurement 
using Zip.  
Inaccuracies 
directly related to 
slow speeds, and 
thus for patients 
with cardiac
disease who walk 
at a slow pace
Farina et 
al.10
Free-living 
Wear the trackers 
during waking 
hours
(except for water-
based activities)
7 consecutive 
days; during 
waking hours
Misfit Shine
Fitbit
Charge HR
Steps Actigraph and
NL2000
Compared to the 
ActiGraph GT3X+, 
the waist-worn 
Misfit Shine had 
highest 
agreement. 
Wrist-worn 
trackers showed
poorer 
agreement to 
reference 
trackers
MWT = minute walk test; PA = physical activity; HR = heart rate; LOS = length of stay; ECG = electrocardiography; AF = atrial 
fibrillation; ICU = intensive care unit; IHD = ischemic heart disease; h = hours; m = minutes; Sensewear = SWA
  
Table 4 Data utility:  Outcomes of the reviewed studies regarding the clinical benefits of wearable trackers 
and their acceptability
Authors Research 
Focus 
Objectives Wearable 
tracker
Main conclusions
Speier et 
al.11
Acceptance, 
adoption or 
abandonment 
Evaluate adherence
rates using 
consumer-grade 
continuous-time HR 
and activity tracker 
over 90 days in a 
group of patients 
with IHD
Fitbit
Charge HR
Using continuous-time activity trackers with 
HR monitors can be effective in a 
telemonitoring application, as patients had 
a high level of adherence (90% median 
usage) and low attrition
(0.09% decrease per day) over a 90-day 
period.
Fausset et 
al.34
Acceptance, 
adoption or 
abandonment 
Attitudes and 
usability issues were 
assessed and 
evaluated within a 
technology 
acceptance 
framework the 
Unified Theory of 
Acceptance and Use 
of Technology 
Fitbit
One
Nike+ 
FuelBand 
Initial attitudes were positive, but after 
using the tracker for two weeks, attitudes 
were mixed. 3 participants indicated they 
would continue using the tracker; whereas, 
5 would abandon the tracker and described 
several issues including inaccurate data 
collected, wasting time, and uncomfortable 
to wear
McMahon 
et al.3
Acceptance, 
adoption or 
abandonment 
To assess short and 
long-term 
experiences of Fitbit 
One in terms of 
acceptance,
ease-of-use, and 
usefulness: domains 
in the technology 
acceptance model.
Fitbit One 91% agreed or strongly agreed that the 
tracker was easy to use, useful & 
acceptable both 10 weeks and 8
months after enrolling in the study. Ratings 
slightly dropped between these time points 
in all survey domains: ease-of-use, 
usefulness and acceptance 
O’Brien et 
al.35
Acceptance & 
wearable 
trackers as   
useful 
measure of 
clinical 
outcomes
To evaluate the 
feasibility and utility 
of activity tracker use 
among older adults 
for
monitoring activity, 
improving self-
efficacy, and health 
outcomes
Nike Fuel Participants found activity trackers easy to 
use, experienced a significant decrease in 
waist circumference. However no change in 
steps taken, calories burned, and self-
efficacy
Kanai et 
al.36
Wearable 
trackers as a 
motivator of 
PA behaviour 
change
To evaluate the 
effect of 
accelerometer-based 
feedback on physical 
activity in 
hospitalized
patients with 
ischemic stroke.
Fitbit One Exercise training combined with 
accelerometer-based feedback effectively 
increased PA in hospitalized patients with 
ischemic stroke
Cook et 
al.37
 
Wearable 
trackers as   
useful 
measure of 
clinical 
outcomes
Examine an activity 
tracker to measure 
PA  during hospital 
recovery after cardiac 
surgery.
Fitbit One There was a significant relationship 
between the number of steps taken in the 
early recovery
period, length of stay, and dismissal 
disposition
Steinhubl 
et al.24
Wearable 
trackers as   
useful 
measure of 
clinical 
outcomes
To determine effect 
of self-applied 
wearable ECG patch
in detecting AF and 
the clinical 
consequences 
iRhythmZio Among individuals at increased risk for AF, 
use of home-based self-applied ECG patch 
facilitated AF diagnosis
Turakhia 
et al.25
Wearable 
trackers as   
useful 
measure of 
clinical 
outcomes
Screening for AF 
using continuous 
ambulatory ECG 
monitoring can 
detect silent AF in 
asymptomatic in 
patients with known 
risk factors
iRhythmZio Tracker is feasible, with AF detected in 1 in 
20 subjects with up to 2 weeks of 
monitoring.
Also detected sustained atrial tachycardia 
and AF in 1 in 9 subjects
PA = physical activity; HR = heart rate; LOS = length of stay; ECG = electrocardiography; 
AF = atrial fibrillation; ICU = intensive care unit; IHD = ischemic heart disease  
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